The relevance of estrogen/antiestrogen actions on non-cancer cells has been demonstrated in experimental models of non-estrogen receptor-expressing cancers, including TNBC, ovarian, and pancreatic cancers [42,155,160]. This evidence concerns the gene ESR1 and cancer.